Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies

The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Namshik, Hwang, Woochang, Tzelepis, Konstantinos, Schmerer, Patrick, Yankova, Eliza, MacMahon, Méabh, Lei, Winnie, M. Katritsis, Nicholas, Liu, Anika, Felgenhauer, Ulrike, Schuldt, Alison, Harris, Rebecca, Chapman, Kathryn, McCaughan, Frank, Weber, Friedemann, Kouzarides, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245040/
https://www.ncbi.nlm.nih.gov/pubmed/34193418
http://dx.doi.org/10.1126/sciadv.abh3032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245040/
https://www.ncbi.nlm.nih.gov/pubmed/34193418
http://dx.doi.org/10.1126/sciadv.abh3032

Ejemplares similares